Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Unique Cellular and Biochemical Features of Human Mitochondrial Peroxiredoxin 3 Establish the Molecular Basis for Its Specific Reaction with Thiostrepton

Antioxidants(2021)10.3390/antiox10020150Source: DataRank Database

Unique Cellular and Biochemical Features of Human Mitochondrial Peroxiredoxin 3 Establish the Molecular Basis for Its Specific Reaction with Thiostrepton is a research paper published in Antioxidants (2021). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: goldTopics (10)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Terri Messier ORCID,Stephanie Milczarek,Alexis Saaman,Stacie L. Beuschel,Uma Gandhi ORCID

Live enrichment

PubMed:33498547 PMC:PMC7909569

National Institutes of Health

Grant: GM072866

Comprehensive Cancer Center at Wake Forest Baptist Medical Center

Grant: P30CA012197

RS Oncology, LLC

Grant: Sponsored Research Agreement

National Institutes of Health

Grant: 5R01GM072866-05

Structures & Redox Chemistry in Sulfinic Acid Reduction

National Institutes of Health

Grant: 3P30CA012197-46S1

Cancer Center Support Grant

goldLicense: CC BY

publisherhttps://www.mdpi.com/2076-3921/10/2/150/pdf

Europe_PMChttps://europepmc.org/articles/PMC7909569

Europe_PMChttps://europepmc.org/articles/PMC7909569?pdf=render

https://doi.org/10.3390/antiox10020150

https://pubmed.ncbi.nlm.nih.gov/33498547

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

peroxiredoxin 3Mitochondrial Reactive Oxygen SpeciesThiostreptonPro-oxidant TherapyTherapeutics. PharmacologyRM1-950Article

Sustainable Development Goals

SDG 3: 3. Good health